David Dornan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Redwood City, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Stephen Rodin, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David Dornan

Form 4 holding CHIEF SCIENTIFIC OFFICER

Elevation Oncology, Inc.

Security class
Restricted Stock Unit
Shares / value
37,500
Estimated value
$19,125
Report date
15 Feb 2024
Price
$0.5100
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF SCIENTIFIC OFFICER

Elevation Oncology, Inc.

Security class
Restricted Stock Unit
Shares / value
28,125
Estimated value
$18,892
Report date
15 Feb 2025
Price
$0.6717
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF SCIENTIFIC OFFICER

Elevation Oncology, Inc.

Security class
Common Stock
Shares / value
5,223
Estimated value
$3,508
Report date
15 Feb 2025
Price
$0.6717
Ownership
Direct
Form 4 holding CHIEF SCIENTIFIC OFFICER

Elevation Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
225,000
Estimated value
Report date
15 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Scientific Officer

Bolt Biotherapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
210,000
Estimated value
Report date
18 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by David Dornan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .